Pharmaceutical Technology2 小时
Bimatoprost by Laboratoires Thea for Ocular Hypertension: Likelihood of Approval
Bimatoprost is under clinical development by Laboratoires Thea and currently in Phase III for Ocular Hypertension.
Pharmaceutical Technology2 小时
H-1337 by D. Western Therapeutics Institute for Open-Angle Glaucoma: Likelihood of Approval
H-1337 is under clinical development by D. Western Therapeutics Institute and currently in Phase II for Open-Angle Glaucoma.
optometryadvisor6 小时
Some Patients With POAG Experience Rapid Visual Field Loss
Some patients with ocular hypertension who develop primary open angle glaucoma experience rapid visual field loss.